Tennant
TNC
65.87
-2.30
-3.37%
Tennant
US · TNC
#3166 by market cap
65.87
-2.30
-3.37%
Live - 5344 symbols - heartbeat 212s ago
· 2026-10-07 19:54
After-hours
65.87
0.00%
- Market cap
- 1.12B
- P/E (TTM)i
- 63.34
- P/Bi
- 2.11
- EPSi
- 2.36
- Div yieldi
- 1.86%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on TNC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.12, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -6.47% YoY
Margins
- Gross margin
- 40.24%
- Operating margin
- 5.68%
- Net margin
- 3.64%
Key ratios & quality
- Enterprise valuei
- 1.31B
- Altman Z-Scorei
- 3.12
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.12B | 1.14B | 1.00B | 1.09B | 1.09B | 1.24B | 1.29B | 1.20B |
| Gross profit | 445.00M | 461.70M | 407.80M | 438.00M | 420.90M | 527.80M | 550.00M | 484.30M |
| Selling & admin expenses | 356.30M | 357.20M | 314.00M | 321.90M | 306.30M | 352.60M | 391.90M | 374.80M |
| Research & development | 30.70M | 32.70M | 30.10M | 32.20M | 31.10M | 36.60M | 43.80M | 41.20M |
| Operating profit | 58.00M | 71.80M | 63.70M | 83.90M | 83.50M | 138.60M | 114.30M | 68.30M |
| Pretax profit | 35.80M | 54.00M | 41.10M | 74.10M | 79.50M | 123.80M | 104.80M | 57.90M |
| Tax | 2.30M | 8.10M | 7.40M | 9.20M | 13.20M | 14.30M | 21.10M | 14.10M |
| Net profit | 33.50M | 45.90M | 33.70M | 64.90M | 66.30M | 109.50M | 83.70M | 43.80M |
| Basic EPS | 2 | 3 | 2 | 4 | 4 | 6 | 4 | 2 |
| Diluted EPS | 1.82 | 2.48 | 1.81 | 3.44 | 3.55 | 5.83 | 4.38 | 2.36 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 290.00M | 318.60M | 303.30M | 291.60M | 297.90M | 324.00M |
| Gross profit | 120.00M | 134.10M | 129.40M | 100.80M | 113.60M | 127.90M |
| Selling & admin expenses | 90.70M | 93.70M | 96.60M | 93.80M | 98.10M | 99.50M |
| Research & development | 9.70M | 9.80M | 10.50M | 11.20M | 10.60M | 12.50M |
| Operating profit | 19.60M | 30.60M | 22.30M | -4.20M | 4.90M | 15.90M |
| Pretax profit | 17.20M | 27.30M | 19.40M | -6.00M | 900.00K | 10.30M |
| Tax | 4.10M | 7.10M | 4.50M | -1.60M | 700.00K | 2.70M |
| Net profit | 13.10M | 20.20M | 14.90M | -4.40M | 200.00K | 7.60M |
| Basic EPS | 1 | 1 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.69 | 1.08 | 0.80 | -0.23 | 0.01 | 0.44 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 468.60M | 481.00M | 493.60M | 526.80M | 575.30M | 569.10M | 576.60M | 599.70M |
| Cash & ST investments | 85.60M | 74.10M | 140.40M | 123.10M | 77.20M | 116.90M | 99.60M | 106.20M |
| Inventory | 135.10M | 150.10M | 127.70M | 160.60M | 206.60M | 175.90M | 183.80M | 198.50M |
| Total assets | 992.50M | 1.06B | 1.08B | 1.06B | 1.09B | 1.11B | 1.19B | 1.27B |
| Total current liabilities | 248.90M | 274.90M | 254.30M | 290.30M | 261.60M | 273.70M | 292.20M | 293.10M |
| Short-term debt | 27.00M | 48.00M | 27.20M | 20.60M | 20.20M | 20.80M | 19.80M | 22.10M |
| Long-term debt | 328.10M | 307.50M | 297.60M | 263.40M | 294.80M | 193.70M | 196.70M | 272.50M |
| Total liabilities | 676,200,000.00 | 701,600,000.00 | 676,500,000.00 | 626,600,000.00 | 613,000,000.00 | 535,100,000.00 | 568,000,000.00 | 665,500,000.00 |
| Total equity | 316.30M | 361.30M | 406.10M | 435.10M | 472.10M | 578.30M | 622.10M | 603.40M |
| Retained earnings | 316.30M | 346.00M | 363.30M | 410.60M | 458.00M | 547.40M | 609.70M | 628.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 550.90M | 574.60M | 598.30M | 599.70M | 611.10M | 613.80M |
| Cash & ST investments | 79.50M | 80.10M | 99.40M | 106.20M | 82.60M | 76.90M |
| Inventory | 191.30M | 195.40M | 205.90M | 198.50M | 204.60M | 201.90M |
| Total assets | 1.18B | 1.24B | 1.26B | 1.27B | 1.28B | 1.27B |
| Total current liabilities | 257.40M | 274.80M | 281.50M | 293.10M | 288.60M | 300.20M |
| Short-term debt | 500.00K | 400.00K | 400.00K | 22.10M | 400.00K | 500.00K |
| Long-term debt | 212.50M | 212.50M | 237.50M | 272.50M | 357.50M | 357.50M |
| Total liabilities | 554,200,000.00 | 587,800,000.00 | 614,200,000.00 | 665,500,000.00 | 743,600,000.00 | 735,600,000.00 |
| Total equity | 626.10M | 653.70M | 642.70M | 603.40M | 533.00M | 535.20M |
| Retained earnings | 617.20M | 632.00M | 641.50M | 628.10M | 562.10M | 564.40M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 80.00M | 71.90M | 133.80M | 69.40M | -25.10M | 188.40M | 89.70M | 65.00M |
| Depreciation & amortization | 54.40M | 54.40M | 53.40M | 53.10M | 48.70M | 51.10M | 55.10M | 58.70M |
| Free cash flow | 58.40M | 33.00M | 103.80M | 46.30M | -54.40M | 164.40M | 68.30M | 42.90M |
| Dividends paid | -15.30M | -16.00M | -16.30M | -17.50M | -18.90M | -20.10M | -21.40M | -21.90M |
| Stock buybacks / issuance | 5.90M | 6.10M | 4.90M | -15.00M | -5.00M | -21.70M | -19.60M | -88.50M |
| Ending cash balance | 86.10M | 74.60M | 141.00M | 123.60M | 77.40M | 117.10M | 99.80M | 106.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -400.00K | 22.50M | 28.70M | 14.20M | -31.20M | 5.00M |
| Depreciation & amortization | 14.00M | 14.70M | 14.70M | 15.30M | 14.90M | 15.00M |
| Free cash flow | -7.50M | 18.60M | 22.20M | 9.60M | -34.50M | -400.00K |
| Dividends paid | -5.60M | -5.40M | -5.40M | -5.50M | -5.50M | -5.30M |
| Stock buybacks / issuance | -20.20M | -13.40M | -22.70M | -32.20M | -60.00M | -500.00K |
| Ending cash balance | 79.50M | 80.10M | 99.40M | 106.40M | 82.60M | 76.90M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.94 | 13.58 | 8.81 | 15.48 | 14.66 | 20.90 | 13.98 | 7.17 |
| ROA %i | 3.36 | 4.46 | 3.14 | 6.05 | 6.18 | 9.96 | 7.27 | 3.56 |
| ROIC %i | 7.81 | 8.61 | 6.38 | 9.50 | 9.34 | 14.97 | 10.74 | 5.60 |
| 5-year avg ROE %i | 11.40 | 10.39 | 9.75 | 9.33 | 12.69 | 14.69 | 14.77 | 14.44 |
| EBIT margin %i | 5.27 | 6.60 | 6.17 | 7.46 | 7.93 | 11.04 | 8.85 | 5.56 |
| FCF / sales %i | 5.20 | 2.90 | 10.37 | 4.24 | -- | 13.22 | 5.31 | 3.56 |
| Current ratioi | 1.88 | 1.75 | 1.94 | 1.81 | 2.20 | 2.08 | 1.97 | 2.05 |
| Quick ratioi | 1.21 | 1.08 | 1.34 | 1.15 | 1.26 | 1.33 | 1.23 | 1.24 |
| Debt / assetsi | 35.78 | 36.30 | 32.65 | 29.14 | 30.63 | 21.77 | 21.38 | 26.07 |
| LT debt / equityi | 104.36 | 93.86 | 80.61 | 66.57 | 66.31 | 38.41 | 37.81 | 51.31 |
| Interest coveragei | 2.54 | 3.56 | 2.99 | 11.15 | 12.20 | 10.17 | 12.52 | 7.43 |
| Revenue CAGR (3Y) %i | 11.44 | 12.05 | -0.07 | -0.98 | -1.35 | 7.50 | 5.66 | 3.29 |
| Net income CAGR (3Y) %i | 1.34 | -0.59 | -- | 24.79 | 13.12 | 48.11 | 8.85 | -12.91 |
| FCF CAGR (3Y) %i | 41.87 | 1.72 | 49.13 | -7.45 | -- | 16.57 | 13.84 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.04 | 9.51 | 8.51 | 7.17 | 5.35 | 3.09 |
| ROA %i | 5.87 | 5.04 | 4.43 | 3.56 | 2.52 | 1.46 |
| ROIC %i | 8.74 | 7.65 | 6.82 | 5.60 | 4.27 | 3.00 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.58 | 6.87 | 6.26 | 5.56 | 4.27 | 3.02 |
| FCF / sales %i | 4.83 | 5.22 | 4.94 | 3.56 | 1.31 | -- |
| Current ratioi | 2.14 | 2.09 | 2.13 | 2.05 | 2.12 | 2.04 |
| Quick ratioi | 1.28 | 1.26 | 1.24 | 1.24 | 1.26 | 1.21 |
| Debt / assetsi | 21.11 | 19.97 | 21.72 | 26.07 | 30.75 | 30.83 |
| LT debt / equityi | 39.83 | 37.97 | 42.53 | 51.31 | 73.81 | 73.36 |
| Interest coveragei | 10.55 | 9.78 | 9.14 | 7.43 | 5.12 | 3.02 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Equipment is the largest reported line at 59.81% of revenue, across 3 reported segments.
- Parts and consumables follows at 21.02%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Equipment59.81%
Parts and consumables21.02%
Service and other19.17%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.